from the end of the fatiguing protocol) were assessed. Results: During the fatiguing protocol, significant decreases in jump height, and increases in contact time were found in both groups from the 15 th second onwards to the end of the fatiguing protocol. Average contact time and jump height were respectively lower (-7%; P=0.018) and higher (+6%; P=0.025) in Carn-BA compared to PLA. After the fatiguing protocol, MVC decreased in both PLA and Carn-BA, but it was higher in Carn-BA compared to PLA (+15%, P=0.012), while CMJ did not change.
Introduction
Muscle performance decreases progressively during exercise because of central and peripheral fatigue. 1 It's becoming very popular among recreational and competitive athletes the ingestion of different types of legal ergogenic aids to counteract the effects of fatigue. 2, 3 Although controversial, 4, 5 chronic supplementation with carnosine together with ß-alanine (Carn-BA), the rate-limiting precursor in carnosine synthesis, 6 has been recently proposed to increase skeletal muscle carnosine levels, [6] [7] [8] which can improve muscle contractility and reduce muscle fatigue. 8, 9 Among several hypotheses, Carn-BA effects have been suggested to rely on its buffering action in the muscle 10 or on its role as a diffusible Ca 2+ /H + exchanger, which would increase cross-bridge formation and force output.
11
Four weeks of L-carnosine or ß-alanine supplementation has been shown to increase muscle carnosine levels up to about 66 % and 64 %, respectively. 12 An amelioration of muscle contractility and exercise performance have been associated to these carnosine increased levels. 6, 8, 13, 14 While the consequences of chronic Carn-BA supplementation have been already extensively investigated, little is known about the effects of acute Carn-BA administration.
Gardner et al. 15 argued that carnosine could be already available inside the muscle fibres few hours after ingestion. Therefore, acute Carn-BA supplementation may be similarly effective in increasing muscle performance. Consequently, athletes could benefit from its ingestion immediately, avoid the nuisance of chronic supplementation, simplify consumption procedures, and reduce the associated costs. Bellinger and coworkers found that acute ingestion of ß-alanine was not associated with improved cycling time trial performance. 16 However, the effects of acute supplementation on high intensity anaerobic tasks yet have to be assessed.
Therefore, this study aimed at assessing the effects of acute Carn-BA supplementation on maximum isometric strength and repeated vertical jumps. Should a higher isometric and jumping performance in Carn-BA compared to PLA be retrieved after a fatiguing protocol, then Carn-BA effects may be claimed to be present also after its acute supplementation. The effects of acute Carn-BA ingestion on rate of perceived effort and muscular pain after a fatiguing protocol were also assessed.
Methods

Participants
Twelve healthy, physically active, male participants (age 23 ± 2 years; stature 1.79 ± 0.09 m; body mass 75.8 ± 9.8 kg; mean ± standard deviation, SD) volunteered for the study.
They were all without any form of neuromuscular and skeletal diseases. The participants were naive to the purpose of the experiments. After full explanation of the experimental design and procedures, each participant gave written informed consent before engaging in the experiments.
The study was approved by the local Ethics Committee and was conducted in accordance with the principles of the 1964 Declaration of Helsinki.
Experimental design
The study has a double blind, randomized, counterbalanced placebo design. All participants reported to the laboratory on three different occasions. The first visit served for familiarization purpose, during which participants were accurately instructed with the experimental setup and procedures. In the two following visits, each participant performed static and dynamic tests with (Carn-BA) or without (placebo-PLA) supplement ingestion, in randomized order.
Carn-BA supplementation involved tablets with a total amount of 2 g of L-carnosine and 2 g of ß-alanine, plus excipients. According to the main formulator of the product (Velleja Research, Piacenza, Italy), the carnosine and β-alanine combination was proposed to maximize the carnosine content within the muscle cells. 10, 17 Placebo tablets contained only excipients. Participants were asked not to engage in physical activity over 24 hours prior to the experiments. All tests were carried out in a climate-controlled laboratory (constant temperature of 21 ± 1 °C and relative humidity of 50 ± 5 %), approximately at the same hour of the day.
Experimental procedures
Initially all participants completed a standardized warm-up which consisted of 10 min of running at a slow pace, two sets of five isometric submaximal contractions and three trials of vertical jumps. between. The highest value obtained was considered as the maximum voluntary contraction (MVC).
During tests, participants seated on a knee-extensor ergometer with the knee joint at 90
degrees. The load cell attached to the ergometer was connected to a carbon shin pad positioned on the dominant leg of the participant by an inextensible steel wire. The position of the subject on the ergometer and the placement of the shin pad on the leg was carefully standardized. To isolate the knee extensor muscles contribution to the force output, limiting accessory muscles involvement, participants were also secured to the ergometer with Velcro straps at the chest.
After the fatiguing protocol, a single MVC determination was immediately repeated.
CMJ. Before the fatiguing protocol and three minutes after the last MVC assessment, 
Results
None of the participants reported the occurrence of side effects following the acute ingestion of Carn-BA, neither during the testing period nor in the next hours or the day after.
MVC pre-and post-fatiguing protocol
As shown in Table 1 with fatigue. In PLA, indeed, the fatiguing protocol decreased CMJ pF by ~ 6 % (P=0.017, ES=0.48, CI= -0.51 -1.48), while in Carn-BA it did not (P=0.107).
Fatiguing protocol
As indicated in Table 2 ANOVA did not disclose significant differences in EMG RMS between Carn-BA and PLA during the fatiguing protocol, as shown in Figure 2 .
Perceived exertion and pain
The general and muscular RPE and the level of muscular pain at 24 and 48 h after the fatiguing protocol in PLA and Carn-BA are provided in Table 3 . Immediately after the fatiguing protocol, less general effort was perceived in Carn-BA than in PLA (-6 %; P=0.042, 
Discussion
The main finding of the present study was that Carn-BA acute supplementation was effective in ameliorating maximum static and dynamic tasks. With Carn-BA, the maximum isometric force dropped to a lesser extent after a 45-s fatiguing protocol. Moreover, jumps height was higher while contact time was lower throughout the fatiguing protocol, compared to PLA. Lastly, despite muscle pain indices at 24 hours were higher with Carn-BA, muscular RPE immediately at the end of the fatiguing protocol did not differ between conditions, and general RPE was lower in Carn-BA. These data suggest that Carn-BA had positive effects on static and dynamic performance during and after a high intensity fatiguing effort even when acutely administered.
Acute effects of Carn-BA on MVC and jump performance before the fatiguing protocol
The influence of acute Carn-BA supplementation on the maximum isometric force and jump performance is a novel finding of this study. Our findings show a higher neuromuscular activation with Carn-BA, suggesting the occurrence of phenomena at central level neuromodulator. 23 However, they do not support the hypothesis of an acute effect of Carn-BA on unfatigued muscle performance. Even though MVC and CMJ pF showed higher values in Carn-BA with respect to PLA, the difference did not achieve statistical significance, suggesting that the tendency of Carn-BA to ameliorate maximum static and dynamic performance needs further investigation. In previous studies, the increase in muscle carnosine levels has been shown to induce positive effects on muscle performance in continuous or intermittent exercise. 13, 24, 25 These observations, though, were made only after chronic supplementation. No studies on the effects of Carn-BA on maximum isometric force output have been performed so far.
Therefore, comparisons with previous findings cannot be made. 
Acute effects of Carn-BA on MVC and jump performance during and after the fatiguing protocol
As expected, MVC decreased after the fatiguing protocol in both Carn-BA and PLA.
However, the MVC post-fatigue value in Carn-BA was higher than in PLA, suggesting that muscle contractile properties were less affected by the fatiguing protocol with acute Carn-BA supplementation. Carn-BA effects on MVC were accompanied by similar effects on EMG activity. In particular, the neural drive was higher in Carn-BA as before fatigue, and neuromuscular activation dropped to a lesser extent after the fatiguing protocol, suggesting that after the fatiguing protocol Carn-BA effects were evident also at the force output level.
Collectively, we cannot exclude that the higher MVC in Carn-BA after the fatiguing protocol could be attributed to phenomena occurring at central level neuromodulator. 23 This explanation, though, may require further investigation.
In addition to these Carn-BA positive effects on MVC, CMJ pF in Carn-BA did not drop after the fatiguing protocol as in PLA (see Table 1 ), even though CMJ height did not change with fatigue. A decrease in jump height would be reasonably expected after a fatiguing jumping exercise. 26, 27 The discrepancy could be possibly explained by the higher number of jumps performed in the two cited studies compared to those in the present investigation.
Moreover, the longer recovery time before performing the CMJ post-fatiguing protocol may have played a role. Indeed, in our study the CMJ measurement was accomplished after MVC assessment, as MVC was chosen as the main parameter to determine the presence of fatigue. the participants to recover from fatigue, at least in part, before maximum jump performance reassessment.
The positive effects of acute Carn-BA supplementation had urther support from the findings during the fatiguing protocol (Table 2) , where Carn-BA condition highlighted a lower average contact time and a higher average jump height. Moreover, Carn-BA counteracted the fall in jump height and the rise in contact time after the first 15 seconds of the fatiguing protocol, as shown in Figure 1 . Compared to PLA, the better jump performance with Carn-BA may be ascribed to the reported amelioration in buffering capacity and/or an increased Ca 2+ unloading at the muscle level, where Carn-BA exerts its primary function. 6-8, 11, 17 Should the Carn-BA-induced increase in buffering capacity be the explanation, 19 muscle contractility may have been considerably preserved in Carn-BA compared to PLA, thus limiting the drop in jumping capacity. On the contrary, should the effect of Carn-BA on dynamic performance be based on higher Ca 2+ unloading at the sarcomere level, 11 leading to an increase in cross-bridge formation and force output, this would anyway explain the present findings. Further studies, though, involving muscle biopsies before and after the same fatiguing protocol would be required to elucidate these or other explanations.
Noticeably, the different behavior in Carn-BA became evident after the first 10 seconds of the fatiguing protocol, leading to the hypothesis that the increased muscle carnosine content exerted an effect few seconds from the beginning of the fatiguing exercise.
Acute effects of Carn-BA supplementation on RPE and pain RPE and pain surveys showed an interesting and unexpected finding supporting the beneficial effects of Carn-BA to improve the performance during and after a fatiguing exercise.
Indeed, RPE at the end of the fatiguing protocol should have been similar in PLA and Carn-BA because of the exhaustive meaning of the fatiguing protocol and of the consequential intensity constraint asked to the participants (all-out continuous jumps). However, while this is 
